Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy

NCT02062632 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02062632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02062632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot, Double-Blind, Randomized, Two-Arm Crossover Study of Doxepin Versus Placebo for Esophagitis-Induced Pain in Patients Receiving Radiotherapy to the Thorax With or Without Chemotherapy
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Terminated
Start date
April 14, 2014
Completion date
November 6, 2017
Enrollment
5 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal carcinoma, hypopharyngeal carcinoma, laryngeal carcinoma, lymphoma, mesothelioma, metastatic malignant neoplasm in the lung, metastatic malignant neoplasm in the pleura, metastatic malignant neoplasm in the spinal cord, non-small cell lung carcinoma, sarcoma, small cell lung carcinoma, thymic carcinoma, thymoma, thyroid gland carcinoma